These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 10893591)

  • 1. Transperineal magnetic resonance image guided prostate biopsy.
    D'Amico AV; Tempany CM; Cormack R; Hata N; Jinzaki M; Tuncali K; Weinstein M; Richie JP
    J Urol; 2000 Aug; 164(2):385-7. PubMed ID: 10893591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.
    Hambrock T; Fütterer JJ; Huisman HJ; Hulsbergen-vandeKaa C; van Basten JP; van Oort I; Witjes JA; Barentsz JO
    Invest Radiol; 2008 Oct; 43(10):686-94. PubMed ID: 18791410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A technique of transrectal ultrasound guided transperineal random prostate biopsy in patients with ulcerative colitis and an ileal pouch.
    Fergany AF; Angermeier KW
    J Urol; 2000 Jan; 163(1):205-6. PubMed ID: 10604348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of transrectal ultrasound guided prostate biopsy on quality of life: a prospective randomized trial comparing 6 versus 12 cores.
    Naughton CK; Miller DC; Yan Y
    J Urol; 2001 Jan; 165(1):100-3. PubMed ID: 11125374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.
    Anastasiadis AG; Lichy MP; Nagele U; Kuczyk MA; Merseburger AS; Hennenlotter J; Corvin S; Sievert KD; Claussen CD; Stenzl A; Schlemmer HP
    Eur Urol; 2006 Oct; 50(4):738-48; discussion 748-9. PubMed ID: 16630688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of three-dimensional 26-core systematic biopsy.
    Kawakami S; Okuno T; Yonese J; Igari T; Arai G; Fujii Y; Kageyama Y; Fukui I; Kihara K
    Eur Urol; 2007 Mar; 51(3):675-82; discussion 682-3. PubMed ID: 16843585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Single Center Evaluation of the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging against Transperineal Prostate Mapping Biopsy: An Analysis of Men with Benign Histology and Insignificant Cancer following Transrectal Ultrasound Biopsy.
    Pal RP; Ahmad R; Trecartan S; Voss J; Ahmed S; Bazo A; Lloyd J; Walton TJ
    J Urol; 2018 Aug; 200(2):302-308. PubMed ID: 29477717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphologic, functional, and metabolic magnetic resonance imaging-guided prostate biopsy in a patient with prior negative transrectal ultrasound-guided biopsies and persistently elevated prostate-specific antigen levels.
    Lichy MP; Anastasiadis AG; Aschoff P; Sotlar K; Eschmann SM; Pfannenberg C; Stenzl A; Claussen CD; Schlemmer HP
    Urology; 2007 Jun; 69(6):1208.e5-8. PubMed ID: 17572221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.
    Wefer AE; Hricak H; Vigneron DB; Coakley FV; Lu Y; Wefer J; Mueller-Lisse U; Carroll PR; Kurhanewicz J
    J Urol; 2000 Aug; 164(2):400-4. PubMed ID: 10893595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of prostate cancer in men with prostate specific antigen greater than 4.0 ng/ml: a randomized study of 6 versus 12 core transperineal prostate biopsy.
    Emiliozzi P; Scarpone P; DePaula F; Pizzo M; Federico G; Pansadoro A; Martini M; Pansadoro V
    J Urol; 2004 Jan; 171(1):197-9. PubMed ID: 14665875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of lateral biopsy specimens during transrectal ultrasound-guided prostate biopsies in Japanese men.
    Shigemura K; Arakawa S; Yamanaka K; Kataoka N; Yuien K; Fujisawa M
    Int J Urol; 2007 Oct; 14(10):935-8. PubMed ID: 17880293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy.
    Sciarra A; Panebianco V; Ciccariello M; Salciccia S; Cattarino S; Lisi D; Gentilucci A; Alfarone A; Bernardo S; Passariello R; Gentile V
    Clin Cancer Res; 2010 Mar; 16(6):1875-83. PubMed ID: 20197480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
    Cirillo S; Petracchini M; Della Monica P; Gallo T; Tartaglia V; Vestita E; Ferrando U; Regge D
    Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer.
    Hara N; Okuizumi M; Koike H; Kawaguchi M; Bilim V
    Prostate; 2005 Feb; 62(2):140-7. PubMed ID: 15389803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
    Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
    J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach.
    Andriole GL; Bullock TL; Belani JS; Traxel E; Yan Y; Bostwick DG; Humphrey PA
    Urology; 2007 Dec; 70(6 Suppl):22-6. PubMed ID: 18194707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
    Stewart CS; Leibovich BC; Weaver AL; Lieber MM
    J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy.
    Satoh T; Matsumoto K; Fujita T; Tabata K; Okusa H; Tsuboi T; Arakawa T; Irie A; Egawa S; Baba S
    Urology; 2005 Jul; 66(1):114-8. PubMed ID: 15992910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk.
    Igel TC; Knight MK; Young PR; Wehle MJ; Petrou SP; Broderick GA; Marino R; Parra RO
    J Urol; 2001 May; 165(5):1575-9. PubMed ID: 11342920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.